The post Phemex Co-hosts LONGITUDE, Spotlighting the Next Era of Crypto Security at Its 6th Anniversary appeared on BitcoinEthereumNews.com. APIA, Samoa, Dec. 12The post Phemex Co-hosts LONGITUDE, Spotlighting the Next Era of Crypto Security at Its 6th Anniversary appeared on BitcoinEthereumNews.com. APIA, Samoa, Dec. 12

Phemex Co-hosts LONGITUDE, Spotlighting the Next Era of Crypto Security at Its 6th Anniversary

APIA, Samoa, Dec. 12, 2025 /PRNewswire/ — Phemex, a user-first crypto exchange, successfully co-hosted the 7th edition of LONGITUDE with Cointelegraph on December 11 at the Rosewood Hotel in Abu Dhabi. Held alongside Abu Dhabi Finance Week, the gathering brought together Web3 leaders and institutional innovators for an evening of strategic dialogue, celebrating Phemex’s 6th anniversary.

The exclusive agenda featured industry heavyweights including Anthony Scaramucci (SkyBridge) and Kristin Smith (Solana Policy Institute), who dissected market trends in the “Solana SZN” panel, while Eli Ben-Sasson (StarkWare) explored the critical role of privacy in a dedicated fireside chat.

Meanwhile, the night’s centerpiece was the “Crypto’s Security Dilemma” panel. Phemex CEO Federico Variola joined Ian Rogers (Ledger) and Dmytro Budorin (Hacken) to address the sector’s most urgent defense challenges. Federico argued that the industry’s standard “reactive” security model is obsolete against modern AI threats. He advocated for a shift to “Predictive Security Architecture,” revealing how Phemex now uses AI to analyze user behavior patterns to stop threats before they materialize.

Federico also used the stage to unveil Phemex’s strategic roadmap, highlighting the incubation of a new Account Abstraction wallet designed to bridge Web2 and Web3.

“Beyond hardening our infrastructure with predictive AI, we are fundamentally evolving the platform,” said Federico. “We are building a holistic ecosystem — combining a CEX, a DEX, and a self-custodial wallet — where security is the anchor that allows users to move seamlessly between custody models.”

As Phemex enters its seventh year, the event underscored the exchange’s commitment to redefining user protection. By fostering high-level dialogue and partnership among decision-makers, Phemex continues to lead the charge in building a transparent, secure, and unified digital asset future.

About Phemex

Founded in 2019, Phemex is a user-first crypto exchange trusted by over 10 million traders worldwide. The platform offers spot and derivatives trading, copy trading, and wealth management products designed to prioritize user experience, transparency, and innovation. With a forward-thinking approach and a commitment to user empowerment, Phemex delivers reliable tools, inclusive access, and evolving opportunities for traders at every level to grow and succeed.

For more information, please visit: https://phemex.com/

Disclaimer: This is a sponsored press release and is for informational purposes only. It does not reflect the views of Crypto Daily, nor is it intended to be used as legal, tax, investment, or financial advice.

Source: https://cryptodaily.co.uk/2025/12/phemex-co-hosts-longitude-spotlighting-the-next-era-of-crypto-security-at-its-6th-anniversary

Market Opportunity
ERA Logo
ERA Price(ERA)
$0.1515
$0.1515$0.1515
-0.39%
USD
ERA (ERA) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26